ClinicalTrials.gg
Drug

Baloxavir clinical trials

Also written Xofluza and S-033188.

studies test it
20
open now
8
in phase 3
14
first study started
2016

How each study uses baloxavir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the baloxavir studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
24 Oct 2018 · XOFLUZA · NDA 210854 (FDA, Drugs@FDA)
European Union
7 Jan 2021 · Xofluza · EMEA/H/C/004974 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Baloxavir Marboxil
16
Baloxavir
4
XOFLUZA®; RO7191686
2

Brand

Xofluza
6

Development codes

S-033188
2

Studies by the year they started

20 studies that test it; most in 2019 (5)

Studies that test baloxavir, by start year
YearStudies
20162
20171
20181
20195
20202
20211
20233
20242
20251
20262

By phase

A phase 1/2 study counts in both.

Phase 2
2
Phase 3
14
Phase 4
3
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 10 · Other 10

Hoffmann-La Roche (8) · Shionogi (2) · University of Oxford (2) · Bassett Healthcare (1) · Children's Hospital of Philadelphia (1) · University of Washington (1) · Capital Medical University (1) · UMC Utrecht (1)

Often tested with

Tested in the same studies.

Oseltamivir (3) · Hydroxychloroquine (2) · Interleukin 1 Receptor Antagonist Protein (2) · Tocilizumab (2) · Aspirin (2) · Baricitinib (2) · Nirmatrelvir and ritonavir drug combination (2) · Molnupiravir (2)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 5, 4 in phase 3

Studies that test baloxavir, phase 3 first.

Studies

Open first, then newest update. How each study uses baloxavir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 20

Given beside what is tested · 1 — baloxavir is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with baloxavir

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call baloxavir · ClinicalTrials.gg INT000987

  • MeSH (NLM) C000628402baloxavirConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 4G86Y4JT3FBALOXAVIRConfirmed FDA, NLM, Wikidata
  • RxNorm 2197842One source FDA
  • Wikidata Q57742876baloxavirConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C166756BaloxavirOne source FDA
  • DrugBank DB15675One source Wikidata

Also registered as baloxavir marboxil (UNII 505CXM6OHG · RxNorm 2099995).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.